BioCentury
ARTICLE | Financial News

Quotient lowers IPO range

April 15, 2014 11:30 PM UTC

Transfusion diagnostics company Quotient Ltd. (Penicuik, U.K.) amended its planned IPO on NASDAQ to lower the proposed price range. The company now plans to sell 5 million shares at $9-$11. At the $10 midpoint, Quotient would raise $50 million and be valued at $143.8 million. Earlier this month, the company said it planned to sell the shares at $14-$16. UBS; Baird; and Cowen are underwriters. ...